References
- Frazier OH. Current status of cardiac transplantation and left ventricular assist devices. Tex Heart Inst J 2010;37: 319–21.
- Deng MC. Orthotopic heart transplantation: highlights and limitations. Surg Clin North Am 2004;84:243–255.
- Kassab GS, Navia JA, March K, Choy JS. Coronary venous retroperfusion: an old concept, a new approach. J Appl Physiol. 2008;104:1266–72.
- Syeda B, Schukro C, Heinze G, Modaressi K, Glogar D, Maurer G, . The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences. J Thorac Cardiovasc Surg. 2004;127:1703–12.
- Wagner FD, Buz S, Knosalla C, Hetzer R, Hocher B. Modulation of circulating endothelin-1 and big endothelin by nitric oxide inhalation following left ventricular assist device implantation. Circulation. 2003;108 Suppl 1:II278–84.
- Harig F, Hoyer E, Labahn D, Schmidt J, Weyand M, Ensminger SM. Refinement of pig retroperfusion technique: Global retroperfusion with ligation of the azygos connection preserves hemodynamic function in an acute infarction model in pigs (Sus scrofa domestica). Comp Med. 2010;60: 38–44.
- von Lüdinghausen M. Clinical anatomy of cardiac veins, Vv. Cardiacae. Surg Radiol Anat 1987;9:159–168.
- Partington MT, Acar C, Buckberg GD, Julia PL. Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium. J Thorac Cardiovasc Surg 1989;97:613–22.
- Raake P, Hinkel R, Kupatt C, von Brühl ML, Beller S, Andrees M, . Percutaneous approach to a stent-based ventricle to coronary vein bypass (venous VPASS): comparison to catheter-based selective pressure-regulated retro-infusion of the coronary vein. Eur Heart J. 2005;26:1228–34.
- Battistini B, Kingma JG. Changes in plasma levels of ET-1 and its precursor, big ET-1, in the arterial and venous circulation following double myocardial ischemia-reperfusion injury in dogs. J Cardiovasc Pharmacol. 2000;36(5 Suppl 1): S215–20.
- Kurita A, Matsui T, Ishizuka T, Takase B, Satomura K. Significance of plasma nitric oxide/endothelial-1 ratio for prediction of coronary artery disease. Angiology. 2005;56: 259–64.
- Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, Hoffmann M, . Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction. Circulation. 2008;118:818–27.
- Zhu SG, Kukreja RC, Das A, Chen Q, Lesnefsky EJ, Xi L. Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function. J Am Coll Cardiol. 2011;57:2181–9.
- Reriani M, Raichlin E, Prasad A, Mathew V, Pumper GM, Nelson RE, . Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. Circulation. 2010;122:958–66.
- Fitzgerald PJ, Hayase M, Yeung AC, Virmani R, Robbins RC, Burkhoff D, . New Approaches and Conduits: In Situ Venous Arterialization and Coronary Artery Bypass. Curr Interv Cardiol Rep. 1999;1:127–137.